| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,953 |
2,461 |
$740K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,124 |
2,413 |
$635K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,390 |
2,018 |
$393K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
515 |
375 |
$290K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
453 |
263 |
$142K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,554 |
1,396 |
$130K |
| 71046 |
Radiologic examination, chest; 2 views |
1,556 |
1,355 |
$79K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,603 |
5,756 |
$68K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
623 |
497 |
$56K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,394 |
1,258 |
$47K |
| 80053 |
Comprehensive metabolic panel |
4,133 |
3,324 |
$46K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
112 |
98 |
$38K |
| 70450 |
Computed tomography, head or brain; without contrast material |
118 |
102 |
$38K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
901 |
773 |
$32K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,373 |
2,040 |
$30K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,561 |
2,734 |
$30K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,266 |
599 |
$26K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
266 |
108 |
$25K |
| 87081 |
|
2,140 |
1,875 |
$23K |
| 80306 |
|
1,059 |
928 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
998 |
894 |
$14K |
| 80061 |
Lipid panel |
1,050 |
926 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,480 |
1,261 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
10,065 |
7,759 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,435 |
1,260 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
251 |
100 |
$10K |
| 87400 |
|
516 |
432 |
$10K |
| 85610 |
|
1,615 |
1,027 |
$10K |
| G0127 |
Trimming of dystrophic nails, any number |
150 |
142 |
$8K |
| 81001 |
|
2,121 |
1,756 |
$8K |
| 84484 |
|
748 |
570 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
260 |
228 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
260 |
228 |
$7K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
418 |
295 |
$7K |
| 73630 |
|
86 |
75 |
$6K |
| 59025 |
Fetal non-stress test |
18 |
12 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
385 |
284 |
$6K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
27 |
25 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
163 |
146 |
$5K |
| 81003 |
|
769 |
666 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,911 |
1,577 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
643 |
543 |
$3K |
| 84439 |
|
401 |
352 |
$3K |
| 82728 |
|
281 |
240 |
$3K |
| 81025 |
|
364 |
302 |
$2K |
| G0400 |
Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels |
12 |
12 |
$2K |
| 86803 |
|
179 |
153 |
$2K |
| 83655 |
|
138 |
133 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
100 |
88 |
$2K |
| 86780 |
|
174 |
154 |
$2K |
| 83690 |
|
370 |
316 |
$1K |
| 85018 |
|
515 |
473 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
131 |
120 |
$1K |
| 87077 |
|
196 |
160 |
$1K |
| 82248 |
|
345 |
263 |
$907.83 |
| 85027 |
|
206 |
190 |
$787.95 |
| 36416 |
|
221 |
195 |
$760.69 |
| 87653 |
|
25 |
24 |
$757.20 |
| 87186 |
|
135 |
111 |
$659.61 |
| 86140 |
|
187 |
142 |
$622.57 |
| 83735 |
|
150 |
104 |
$590.25 |
| 86850 |
|
129 |
120 |
$492.64 |
| 83605 |
|
87 |
62 |
$373.77 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
13 |
13 |
$320.46 |
| 71045 |
Radiologic examination, chest; single view |
149 |
129 |
$268.91 |
| 87340 |
|
32 |
27 |
$234.74 |
| 86901 |
|
107 |
96 |
$222.48 |
| 87467 |
|
14 |
12 |
$210.70 |
| 86900 |
|
90 |
83 |
$185.40 |
| 87210 |
|
39 |
32 |
$150.00 |
| 82950 |
|
14 |
14 |
$134.01 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
21 |
14 |
$109.86 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
475 |
378 |
$61.48 |
| 85652 |
|
39 |
25 |
$50.22 |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,150 |
1,632 |
$45.53 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,907 |
1,390 |
$10.77 |
| J2704 |
Injection, propofol, 10 mg |
1,257 |
609 |
$8.10 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,373 |
670 |
$5.01 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
418 |
339 |
$4.37 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
634 |
534 |
$2.01 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
995 |
790 |
$1.54 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
442 |
356 |
$0.56 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
362 |
304 |
$0.49 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
22 |
13 |
$0.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
341 |
283 |
$0.06 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
243 |
182 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
94 |
66 |
$0.00 |
| J3490 |
Unclassified drugs |
545 |
303 |
$0.00 |
| A9270 |
Non-covered item or service |
128 |
63 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
89 |
54 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
41 |
35 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
18 |
12 |
$0.00 |